Journal of Pharmacy and Pharmacology · 1981 · 30 citations · 15 references
MedicinePharmacologyExperimental PharmacologyNeuropharmacologyPharmacodynamicsCardiovascular Effects Of AnesthesiaSerotonergic PharmacologyVasoactive MedicationsAdrenergic AntagonistsBlood PressureBlood Pressure PharmacodynamicsGanglionic BlockersSerotonin AntagonistsVasopressor PharmacodynamicsVasopressor PharmacologyVasopressor Responsiveness
5-Hydroxytryptamine (5-HT) administered intravenously (i.v., 1--30 micrograms kg-1) to ganglion-blocked anaesthetized dogs produced dose-related increases in diastolic blood pressure and we have analysed the mechanism involved. Cyproheptadine and methysergide (10--100 micrograms kg-1 i.v.) were potent and specific antagonists of the 5-HT induced rise in blood pressure, while the alpha-adrenoceptor blocking agent phentolamine (0.3--3 mg kg-1 i.v.) also caused dose-related inhibition. Syrosingopine pretreatment converted the vasopressor action of 5-HT to a vasodepressor action and acute bilateral adrenalectomy caused a marked reduction in the 5-HT-induced rise in blood pressure. In two dogs, 5-HT (30 micrograms kg-1 i.v.) markedly increased the venous plasma concentrations of noradrenaline and adrenaline. We concluded that the 5-HT-induced rise in diastolic pressure in the ganglion blocked anaesthetized dog is due largely to the release of catecholamines of which a substantial component is from the adrenal gland. The rise in diastolic blood pressure is specifically blocked by low doses of cyproheptadine and methysergide suggesting that the release of catecholamines is mediated by specific 5-HT receptors located mainly within the adrenal medulla.
15
TWO KINDS OF TRYPTAMINE RECEPTOR
J. H. Gaddum, Zuleika P. Picarelli · British Journal of Pharmacology and Chemotherapy · 1957 · 843 citations · Full text
Medicine, Neurobiology, Pharmacology +14
W. W. Douglas, Tomio Kanno, Sanford R. Sampson · The Journal of Physiology · 1967 · 202 citations
Medicine, Neurobiology, Pharmacology +17